Effect of heartfulness meditation on loneliness and sleep in physicians and advance practice providers

ISRCTN ISRCTN85787008
DOI https://doi.org/10.1186/ISRCTN85787008
ClinicalTrials.gov (NCT) Nil Known
Clinical Trials Information System (CTIS) Nil Known
Protocol serial number IRB number 1568071-3
Sponsor WellSpan Health
Funder Investigator initiated and funded
Submission date
05/01/2021
Registration date
08/01/2021
Last edited
09/03/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Loneliness poses a significant health problem for a sizeable part of the population with increased risks in terms of depression, anxiety, suicidal ideation, health behavior and health care utilization. The medical profession is reported to be one of the loneliest professions of all.
Perception of loneliness can also be influenced by the relationship to one’s own self and sleep. Wellness events and meditation practices may have a positive impact on burnout. Heartfulness meditation practice has been shown to improve wellbeing and sleep. Heartfulness meditation is a simple heart-based meditation system aimed at attaining a balanced state of mind by asking the participants to focus on the source of light within the heart. This study will investigate whether using this novel approach of a heart-based meditation program leads to measurable changes in improvement of sleep and perception of loneliness in physicians and advance practice clinicians.

Who can participate?
All physicians and advance practice providers of Wellspan

What does the study involve?
A survey monkey questionnaire with baseline characteristics and PSQI questionnaire and UCLA loneliness scale will be sent to all physicians and APCs of Wellspan from the research department. Those who respond to the survey will be included in the study. Those willing to participate in mediation program to improve sleep will be randomized into two groups. One group receives instructions whereas the other group does not. A repeat UCLA loneliness and PSQI questionnaires will be sent to the initial respondents and divided into meditation group and the control group and the no interest group. Data from participants who complete survey questions will be collected at the baseline and intervention weeks respectively.

What are the possible benefits and risks of participating?
Participants who complete the meditation session may be able to have an improvement of sleep and/or perception of loneliness. Stress and burnout along with sleep and loneliness scores may be improved as the subjects become less reactive to worrisome thoughts.
Some of the participants may have no benefit from meditation. As this is voluntary participation, it may take around 15 minutes of the participant’s time per day during the intervention period.

Where is the study run from?
Wellspan Health (USA)

When is the study starting and how long is it expected to run for?
February 2020 to October 2020

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Jayaram Thimmapuram, drthimmapuram@yahoo.com

Contact information

Dr Jayaram Thimmapuram
Scientific

2780, Meadow cross Way
York
17402
United States of America

ORCiD logoORCID ID 0000-0002-3189-3863
Phone +1 717-851-2345
Email drthimmapuram@yahoo.com

Study information

Primary study designInterventional
Study designSingle institutional randomized controlled prospective study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleEffect of heartfulness meditation on loneliness and sleep in physicians and advance practice providers during COVID-19
Study objectives1. There is a high burden of loneliness in physicians and advance practice clinicians
2. PSQI scores will correlate with scores of loneliness (poor sleep with higher loneliness)
3. Heartfulness meditation practice will be associated with subjects’ improved sleep and loneliness scores
Ethics approval(s)Approved 06/07/2020, Wellspan IRB (1001, S George St, York, Pennsylvania - 17403, USA; +1 717 8512223; irb@wellspan.org), ref: 1568071-3
Health condition(s) or problem(s) studiedLoneliness and sleep in physicians and advance practice providers
InterventionAfter the enrollment of the participants through email surveys, computerized randomization was performed.

Heartfulness Meditation Audio links were provided to the Heartfulness meditation group to perform meditation for 15 minutes per day for 4 weeks.

The control group continued with their usual routine.

Assessments were made at baseline and 4 weeks.
Intervention typeBehavioural
Primary outcome measure(s)

1. Loneliness measured using UCLA Loneliness score at baseline and 4 weeks
2. Sleep was assessed using the Pittsburgh Sleep Quality Index at baseline and 4 weeks

Key secondary outcome measure(s)

There are no secondary outcome measures

Completion date12/10/2020

Eligibility

Participant type(s)Health professional
Age groupAdult
SexAll
Target sample size at registration200
Total final enrolment155
Key inclusion criteriaAny employee who is a physician or an advance practice provider willing to participate
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment21/07/2020
Date of final enrolment10/08/2020

Locations

Countries of recruitment

  • United States of America

Study participating centre

Wellspan Health
1001, S George St
York
17403
United States of America

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
IPD sharing planThe current data sharing plans for this study are unknown and will be available at a later date

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 17/03/2021 09/03/2021 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

09/03/2021: Publication reference added.
08/01/2021: Trial’s existence confirmed by Wellspan Health.